Semaglutide (1 Mg Dose)

DRUG4 trials

Sponsors

Geisinger Clinic, Second Affiliated Hospital of Guangzhou Medical University, Eighth Affiliated Hospital, Sun Yat-sen University, Tianjin Medical University

Conditions

Diabetes Mellitus, Type 2Nonalcoholic Fatty Liver Disease (NAFLD) With History of Diabetes MelitusObesity Type 2 Diabetes MellitusType 2 DiabetesType 2 Diabetes Mellitus (T2DM)

Phase 1

Triple Hypoglycemic Regimens In Patients With Newly Diagnosed Type 2 Diabetes Mellitus

RecruitingNCT07374328

Second Affiliated Hospital of Guangzhou Medical UniversityType 2 Diabetes

Start: 2025-06-01End: 2026-08-31Target: 240Updated: 2026-01-28

Phase 4

Treatment of GLP-1 for Diabetic Bariatric Patients

TerminatedNCT04624672

Geisinger ClinicDiabetes Mellitus, Type 2

Start: 2021-08-25End: 2022-08-17Updated: 2023-11-14

Unknown Phase

Fecal Microbiota Transplantation (FMT) Combined With Calorie-Restricted Diet and Semaglutide in Patients With Obesity and Type 2 Diabetes

Not yet recruitingNCT07599046

Eighth Affiliated Hospital, Sun Yat-sen UniversityObesity Type 2 Diabetes Mellitus

Start: 2026-04-30End: 2029-12-30Target: 20Updated: 2026-05-20

Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semaglutide

Not yet recruitingNCT07713992

Tianjin Medical UniversityNonalcoholic Fatty Liver Disease (NAFLD) With History of Diabetes Melitus, Type 2 Diabetes Mellitus (T2DM)

Start: 2026-09-15End: 2028-02-01Target: 72Updated: 2026-07-20